Asset Inc accumulated 69,983 shares. Profit Inv Mngmt Lc invested in 6,609 shares or 0.88% of the stock. Nelson Van Denburg Campbell Wealth …
Bibey Post · 12h
AMGN closed May 9, 2018's trading session at $169.63. In the past year, the stock has hit a 52-week low of $152.16 and 52-week high of $201.23. Amgen stock has been showing support around $165.65 and resistance in the $172.53 range. Technical indicators ...
Among other developments over the week, Regeneron (REGN - Free Report) and Sanofi announced plans to lower the price of Praluent, while Amgen (AMGN - Free Report ... Gilead is a Zacks Rank #2 (Buy) stock. You can see the complete list of today’s Zacks ...
Mr. Anthony C. Hooper is the Executive Vice President - Global Commercial Operations of Amgen Inc. From March 2010 to October 2011, Mr. Hooper was Senior Vice President, Commercial Operations and President, U.S., Japan and Intercontinental of BMS.
Reuters · 12d
Amica Mutual Insurance Co. cut its stake in shares of Amgen (NASDAQ:AMGN) by 15.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 35,770 shares of the medical research companys stock after selling 6,509 shares ...
4-Traders · 1mon
The biotech sector was in focus last week with Protagonist's stock plunging on news of discontinuation of a phase IIb study and Verona Pharma stock surging on positive top-line data from COPD study among others.
Mr. Brian M. McNamee is the Executive Vice President - Full Potential Initiatives of Amgen Inc. Mr. McNamee joined the Company in June 2001 as Senior Vice President, Human Resources. From November 1999 to June 2001, Mr. McNamee served as Vice President of ...
Reuters · 12d
AMGN closed Mar 28, 2018's trading session at $170.46. In the past year, the stock has hit a 52-week low of $152.16 and 52-week high of $201.23. Amgen stock has been showing support around $165.85 and resistance in the $174.81 range. Technical indicators ...